[en] The present study was undertaken to examine a possible effect of aprotinin, a 6.5-kDa polypeptide with an inhibitory effect on proteolysis, on aminoglycoside nephrotoxicity. Experimental animals (female Sprague-Dawley rats, 175-200 g body wt) were treated for 4 days with 40 mg/kg gentamicin given ip at 12-hr intervals. Aprotinin (40,000 kIU per animal) was infused i.v. over a period of 8 days, using subcutaneously implanted miniosmotic pumps. In protocol A, infusion pumps were placed 4 days before starting gentamicin treatment. In protocol B, pumps were implanted 15-18 hr prior to first gentamicin administration. In addition to rats exposed to both gentamicin and aprotinin (GAP), animals were treated with gentamicin ip+saline i.v. (G), saline ip+aprotinin i.v. (AP), or received only saline by both routes of administration (C). All rats were terminated 4 days after the end of gentamicin dosing. One hour before sacrifice, 200 microCi of [3H]thymidine was given ip to each animal in order to monitor cell turnover in renal tissue. The kidneys were analyzed with respect to (i) histopathological alterations and renal dysfunction, (ii) aminoglycoside tissue accumulation, and (iii) tubular regeneration (measurement of cell proliferation). In animals receiving aprotinin alone, histological examination of renal cortex on paraffin sections disclosed mild tubular injury with focal cell necrosis. In plastic-embedded tissue, proximal tubule epithelium was characterized by the presence of numerous inclusions densely stained with toluidine blue. At the ultrastructural level, these inclusions appeared filled with amorphous electron-dense material. In gentamicin-treated animals, cortical drug accumulation reached values higher than 0.3 mg/g renal tissue, but a significant 30-40% decrease of gentamicin accumulation was noted in GAP groups, compared to G groups. Histological examination of renal cortex (paraffin sections) revealed the development of acute tubular necrosis in both G and GAP groups. Tubular injury was accompanied by mild renal dysfunction, as shown by the level of serum creatinine which was increased almost 3-fold in the G group, compared to C and AP groups. Aprotinin infusion produced a further increase of serum creatinine, particularly in protocol A where it was 72% higher for the GAP group than for the G group. In both G and GAP groups, postnecrotic tubular regeneration was evidenced by determining the rate of DNA synthesis and the frequency of S-phase cells in renal cortex. Both methods gave consistent results and showed a 8- to 13-fold increase of cell proliferation in groups receiving gentamicin alone, compared to C groups.
Beauchamp, D., Laurent, G., Maldague, P., Abid, S., Kishore, B. K., and Tulkens, P. M. (1990). Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J. Pharmacol. Exp. Ther. 255, 858-866.
Beauchamp, D., Gourde, P., and Bergeron, M. G. (1991). Subcellular distribution ofgentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob. Agents Chemother. 35, 2173-2179.
Brasseur, R., Laurent, G., Ruysschaert, J. M., and Tulkens, P. (1984). Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochem. Pharmacol. 33, 629-637.
Burton, K. (1956). A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62, 315-323.
Carlier, M. B., Laurent, G., Claes, P. J., Vanderhaeghe, H. J., and Tulkens, P. M. (1983). Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: In vitro comparative studies. Antimicrob, Agents Chemother. 23, 440-449.
Cojocel, C., Doctu, N., Maita, K., Sleight, S. D., and Hook, J. B. (1983). Effects of aminoglycosides on glomerular permeability, tubular reabsorption, and intracellular catabolism of the cationic low-molecular weight protein lysozyme. Toxicol. Appl. Pharmacol. 68, 96-109.
De Broe, M. E., Paulus, G. J., Verfooten, G. A., Roels, F., Buyssens, N., Wedeen, R., Van Hoof, F., and Tulkens, P. M. (1984). Early effects of gentamicin, tobramycin, and ammikacin on the human kidney. Kidney Int. 25, 643-652.
Fritz, H., and Wunderer, G. (1983). Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneim. Forsch. Drug Res. 33, 479-494.
Gilbert, D. N., Wood, C. A., Kohlhepp, S. J., Kohnen, P. W., Houghton, D. C., Finkbeiner, H. C., Lindsley, J., and Bennett, W. M. (1989). Polypaspartic acid prevents experimental aminoglycoside nephrotoxicity. J. Infect. Dis. 159, 945-953.
Giuliano, R. A., Paulus, G. J., Verpooten, G. A., Pattyn, V. M., Pollet, D. E., Nouwen, E. J., Laurent, G., Carlier, M. B., Maldague, P., Tulkens, P. M., and De Broe, M. E. (1984). Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int. 26, 838-847.
Giurgea-Marion, L., Toubeau, G., Laurent, G., Heuson-Stiennon, J. A., and Tulkens, P. M. (1986). Impairment of lysosome-pinocytic vesicle fusion in rat proximal tubules after treatment with gentamicin at low dose. Toxicol. Appl. Pharmacol. 86, 271-285.
Houghton, D. C., Hartnett, M. V., Campbell-Boswell, M. V., Porter, G., and Bennett, W. (1976). A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am. J. Pathol. 82, 589-612.
Houghton, D. C., Plamp, C. E., De Fehr, J. M., Bennett, W. M., Porter, G., and Gilbert, D. (1978). Gentamicin and tobramycin nephrotoxicity: A morphologic and functional comparison in the rat. Am. J. Pathol. 93, 137-152.
Just, M., Erdmann, G., and Habermann, E. (1977). The renal handling of polybasic drugs. I. Gentamicin and aprotinin in intact animals. Naunyn-Schmiedeberg’s Arch. Pharmacol. 300, 57-66.
Kahlmeter, G., and Dahlager, J. I. (1984). Aminoglycoside toxicity: A review of clinical studies published between 1975 and 1982. J. Antimicrob. Chemother. 13(Suppl. A), 9-22.
Kishore, B. K., Kallay, Z., Lambricht, P., Laurent, G., and Tulkens, P. M. (1990b). Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. J. Pharmacol. Exp. Ther. 255, 867-874.
Kishore, B. K., Lamsricht, P., Laurent, G., Maldague, P., Wagner, R., and Tulkens, P. M. (1990b). Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic, and poly-D-glutamic acids. J. Pharmacol. Exp. Ther. 255, 875-885.
Kohlhepp, S. J., Mc Gregor, D. N., Cohen, S. J., Kohlhepp, M. E., and Gilbert, D. N. (1992). Determinants of the in vitro interaction of polyaspartic acid and aminoglycoside antibiotics. J. Pharmacol. Exp. Ther. 263, 1464-1470.
Kosek, J. C., Mazze, R. I., and Cousins, M. J. (1974). Nephrotoxicity of gentamicin. Lab. Invest. 30, 48-57.
Laurent, G., Carlier, M. B., Rollmann, B., Van Hoof, F., and Tulkens, P. (1982). Mechanism of aminoglycoside-induced lysosomal phospholipidosis: In vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31, 3861-3870.
Laurent, G., Kishore, B. K., and Tulkens, P. M. (1990). Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem. Pharmacol. 40, 2383-2392.
Laurent, G., Maldague, P., Carlier, M. B., and Tulkens, P. M. (1983). Increased DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob. Agents Chemother. 24, 586-593.
Laurent, G., Toubeau G., Heuson-Stiennon, J. A., Tulkens, P. M., and Maldague, P. (1988). Kidney tissue repair after nephrotoxic injury: Biochemical and morphological characterization. CRC Crit. Rev. Toxicol. 19, 147-183.
Laurent, G., and Tulkens, P. M. (1987). Aminoglycoside neprhotoxicity: Cellular and molecular aspects. IS I Atlas Sci. Pharmacol. 1, 40-44.
Lietman, P. S. (1985). Aminoglycosides and spectinomycin: Aminocyclitols. In “Principles and Practice of Infectious Diseases” (G. L. Mandell, R. G. Douglas, and J. E. Bennett, Eds.), pp. 192-206. Wiley, New York.
Mathews, A., and Bailie, G. R. (1987). Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services. J. Clin. Pharm. Ther. 12, 273-291.
Mingeot-Leclercq, M. P., Laurent, G., and Tulkens, P. M. (1988). Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases. Biochem. Pharmacol. 37, 591-599.
Morin, N. J., Laurent, G., Nonclercq, D., Toubeau, G., Heuson-Stiennon, J. A., Bergeron, M. G., and Beauchamp, D. (1992), Epidermal growth factor (EGF) accelerates renal tissue repair in a rat model of gentamicin nephrotoxicity. Am. J. Physiol. 263, F806-F811.
Munro, H. N., and Fleck, A. (1966). The determination of nucleic acids. Methods Biochem. Anal. 14, 113-176.
Nonclercq, D., Toubeau, G., Laurent, G., Tulkens, P. M., and Heuson'Stiennon, J. A. (1989). Tissue injury and repair in the rat kidney after exposure to cisplatin and carboplatin. Exp. Mol. Pathol. 51, 123-140.
Nonclercq, D., Wrona, S., Toubeau, G., Zanen, J., Heuson-Stiennon, J. A., Schaudies, R. P., and Laurent, G. (1992), Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: A time'COurse study. Renal Failure 14, 507-521.
Price, K. (1986). Aminoglycoside research 1975-1985: Prospects for development of improved agents. An timi crob. Agents Che mother. 29, 543-548.
Ramsammy, L. S., Josepovitz, C., Lane, B. P., and Kaloyanides, G. J. (1989). Polyaspartic acid protects against gentamicin nephrotoxicity in the rat. J. Pharmacol. Exp. Ther, 250, 149-153.
Sande, M. A., and Mandell, G. L. (1985). Antimicrobial agents: The aminoglycosides. In “The Pharmacological Basis of Therapeutics” (A. Goodman Gilman, L. S. Goodman, T. W. Rail, and F. Murad, Eds.), pp. 1150-1169. Macmillan, New York.
Silverblatt, F. J., and Kuehn, C. (1979). Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 15, 335-345.
Solez, K. (1984). The pathology and pathogenesis of human “acute tubular necrosis.” In “Acute Renal Failure” (K. Solez, and A. Whelton, Eds.), pp. 17-42. Dekker, New York.
Sundt, T. M., Kouchoukos, N. T., Saffitz, J. E., Murphy, S. F., Wareing, T. H., and Stahl, D. J. (1993). Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Annal. Thorac. Surg. 55, 1418-1424.
Toback, F. G. (1992). Regeneration after acute tubular necrosis. Kidney Int. 41, 226-246.
Toubeau, G., Laurent, G., Carlier, M. B., Abid, S., Maldague, P., Heuson-Stiennon, J. A., and Tulkens, P. M. (1986). Tissue repair in rat kidney cortex following short treatment with aminoglycosides at low doses: A comparative biochemical and morphometric study. Lab. Invest. 54, 385-393.
Toubeau, G., Nonclercq, D., Zanen, J., Lambricht, P., Tulkens, P. M., Heuson-Stiennon, J. A., and Laurent, G. (1991). Distribution of epidermal growth factor in the kidneys of rats exposed to amikacin. Kidney Int. 40, 691-699.
Tulkens, P. M. (1986). Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives. Am. J. Med. 80(Suppl. 6B), 105-114.
Tulkens, P. M., De Broe, M. E., Maldague, P., and Heuson-Stiennon, J. A. (1984). Lysosomal alterations in aminoglycoside-induced acute renal failure. In “Acute Renal Failure—Correlations between Morphology and Function” (K. Solez and A. Whelton, Eds.), pp. 299-327. Dekker, New York.
Tulkens, P. M., and Laurent, G. (1984). Mechanisms of aminoglycoside-induced nephrotoxicity: A review of experimental studies in animals with gentamicin and four other aminoglycosides (amikacin, tobramycin, netilmicin and dibekacin) at low doses. Chemioterapia III(Suppl. 5), 60-71.
Yarger, W. E., Newman, W. J., and Klotman, P. E. (1987). Renal effects of aprotinin after 24 hours of unilateral ureteral obstruction. Am. J. Physiol. 253, F1006-F1014.